FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 30.5

Change

+0.68 (+2.28)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+1.19 (+0.92%)

USD 17.84B
VOT Vanguard Mid-Cap Growth Index ..

+2.70 (+1.04%)

USD 15.74B
IJK iShares S&P Mid-Cap 400 Growth..

+0.63 (+0.69%)

USD 9.31B
XMMO Invesco S&P MidCap Momentum ET..

+1.10 (+0.88%)

USD 4.07B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+0.84 (+0.74%)

USD 1.13B
CWS AdvisorShares Focused Equity E..

+0.40 (+0.61%)

USD 0.18B
ETHO Amplify ETF Trust

+0.43 (+0.71%)

USD 0.18B
IPO Renaissance IPO ETF

+0.71 (+1.60%)

USD 0.16B
BFOR Barron's 400 ETF

+0.56 (+0.76%)

USD 0.15B
PEXL Pacer US Export Leaders ETF

+0.32 (+0.66%)

USD 0.06B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.15% 94% A 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.15% 88% B+ 80% B-
Trailing 12 Months  
Capital Gain 22.74% 89% A- 80% B-
Dividend Return 0.62% 43% F 7% C-
Total Return 23.36% 89% A- 78% C+
Trailing 5 Years  
Capital Gain -12.86% 6% D- 35% F
Dividend Return 2.45% 17% F 6% D-
Total Return -10.41% 6% D- 20% F
Average Annual (5 Year Horizon)  
Capital Gain -1.09% 11% F 26% F
Dividend Return -0.41% 11% F 19% F
Total Return 0.69% 61% D- 18% F
Risk Return Profile  
Volatility (Standard Deviation) 30.19% 28% F 35% F
Risk Adjusted Return -1.34% 11% F 20% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.